scholarly article | Q13442814 |
P356 | DOI | 10.1007/S10096-012-1586-X |
P698 | PubMed publication ID | 22402816 |
P2093 | author name string | A Berger | |
P M Hauser | |||
I A Hauser | |||
O Jung | |||
H Geiger | |||
K P Hunfeld | |||
L L Presti | |||
E H Scheuermann | |||
R U Pliquett | |||
A Asbe-Vollkopf | |||
P2860 | cites work | Molecular evidence of nosocomial Pneumocystis jirovecii transmission among 16 patients after kidney transplantation | Q24652970 |
An outbreak of Pneumocystis jiroveci pneumonia with 1 predominant genotype among renal transplant recipients: interhuman transmission or a common environmental source? | Q28296417 | ||
A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group | Q29614889 | ||
Molecular evidence of interhuman transmission of Pneumocystis pneumonia among renal transplant recipients hospitalized with HIV-infected patients | Q35880726 | ||
Pneumocystis carinii pneumonia in Hong Kong: a 10 year retrospective study. | Q36358046 | ||
Typing of Pneumocystis carinii f. sp. hominis by single-strand conformation polymorphism of four genomic regions | Q36547938 | ||
Critical care management and outcome of severe Pneumocystis pneumonia in patients with and without HIV infection | Q36642119 | ||
Acute respiratory failure due to Pneumocystis pneumonia: outcome and prognostic factors | Q37198240 | ||
Fact or fiction: does the non-HIV/AIDS immunosuppressed patient need Pneumocystis jiroveci pneumonia prophylaxis? An updated literature review | Q37634160 | ||
Outbreaks and clustering of Pneumocystis pneumonia in kidney transplant recipients: a systematic review | Q37859791 | ||
KDIGO clinical practice guideline for the care of kidney transplant recipients | Q39936865 | ||
A prospective longitudinal analysis of cytomegalovirus (CMV)-specific CD4+ and CD8+ T cells in kidney allograft recipients at risk of CMV infection | Q43232907 | ||
Nosocomial Pneumocystis jirovecii pneumonia: lessons from a cluster in kidney transplant recipients. | Q43853029 | ||
Cluster outbreak of Pneumocystis pneumonia among kidney transplant patients within a single center | Q43868638 | ||
Risk factors for Pneumocystis carinii pneumonia in kidney transplant recipients: a case-control study | Q44585215 | ||
Analysis of USRDS: incidence and risk factors for Pneumocystis jiroveci pneumonia | Q44773073 | ||
A murine model of dual infection with cytomegalovirus and Pneumocystis carinii: effects of virus-induced immunomodulation on disease progression | Q45437756 | ||
Evolving health effects of Pneumocystis: one hundred years of progress in diagnosis and treatment. | Q45956198 | ||
Lack of improvement in renal allograft survival despite a marked decrease in acute rejection rates over the most recent era. | Q47206753 | ||
CMV in kidney transplantation: a single center experience over 22 years | Q47656783 | ||
Rejection treatment and cytomegalovirus infection as risk factors for Pneumocystis carinii pneumonia in renal transplant recipients. | Q51012954 | ||
Successful management of pulmonary tuberculosis in renal allograft recipients in a single center | Q57371736 | ||
Molecular evidence of interhuman transmission in an outbreak ofPneumocystis jiroveciipneumonia among renal transplant recipients | Q61681924 | ||
European best practice guidelines for renal transplantation. Section IV: Long-term management of the transplant recipient | Q78669607 | ||
Transmission of Pneumocystis species among renal transplant recipients | Q80094393 | ||
[Cotrimoxazole Pneumocystis jiroveci pneumonia treatment failure: co-infection cytomegalovirus role?] | Q80157095 | ||
Pneumocystis jiroveci pneumonia (PCP) in HIV-1-negative patients: a retrospective study 2002-2004 | Q80497353 | ||
Risk factors for Pneumocystis jiroveci pneumonia (PcP) in renal transplant recipients | Q82430801 | ||
Outbreak of Pneumocystis jiroveci pneumonia in renal transplant recipients: P. jiroveci is contagious to the susceptible host | Q84379727 | ||
A cluster of Pneumocystis jirovecii infection among outpatients with rheumatoid arthritis | Q84512442 | ||
P433 | issue | 9 | |
P921 | main subject | Cytomegalovirus | Q6946 |
pneumonia | Q12192 | ||
Pneumocystis jirovecii | Q134478 | ||
P304 | page(s) | 2429-2437 | |
P577 | publication date | 2012-03-09 | |
P1433 | published in | European Journal of Clinical Microbiology & Infectious Diseases | Q15754378 |
P1476 | title | A Pneumocystis jirovecii pneumonia outbreak in a single kidney-transplant center: role of cytomegalovirus co-infection | |
P478 | volume | 31 |
Q64906821 | A Molecular Window into the Biology and Epidemiology of Pneumocystis spp. |
Q50789740 | Aetiology and outcome of pneumoniae in HIV-positive patients in the antiretroviral era. |
Q89650080 | Evaluation of the performance of DiaSorin molecular Pneumocystis jirovecii-CMV multiplex real-time PCR assay from bronchoalveolar lavage samples |
Q35500780 | Fulminant hepatic failure and acute renal failure as manifestations of concurrent Q fever and cytomegalovirus infection: a case report |
Q62241392 | Infección nosocomial en el paciente receptor de un trasplante de órgano sólido o de precursores hematopoyéticos |
Q29994504 | Investigating Clinical Issues by Genotyping of Medically Important Fungi: Why and How? |
Q35561221 | New Short Tandem Repeat-Based Molecular Typing Method for Pneumocystis jirovecii Reveals Intrahospital Transmission between Patients from Different Wards |
Q37305589 | Outbreak of pneumocystis pneumonia in renal and liver transplant patients caused by genotypically distinct strains of Pneumocystis jirovecii |
Q48149271 | Pneumocystis Pneumonia in Solid-Organ Transplant Recipients |
Q59336177 | Pneumocystis jiroveci pneumonia in kidney and simultaneous pancreas kidney transplant recipients in the present era of routine post-transplant prophylaxis: risk factors and outcomes |
Q42272280 | Pneumocystis pneumonia in solid organ transplantation |
Q33671565 | Prospective, comprehensive, and effective viral monitoring in Cuban children undergoing solid organ transplantation |
Q43248365 | Reply to Hauser et Al. |
Q41605436 | Risk factors of Pneumocystis pneumonia in solid organ recipients in the era of the common use of posttransplantation prophylaxis |
Q58415922 | Severe infections requiring intensive care unit admission in kidney transplant recipients: impact on graft outcome |
Q36884505 | Varicella-like cutaneous toxoplasmosis in a patient with aplastic anemia |
Q91911376 | [Infectious diseases in immunocompromised patients] |
Search more.